Family History and Risk of Bladder Cancer: An Analysis Accounting for First- and Second-degree Relatives

Author:

Yu Evan Yi-Wen123ORCID,Stern Mariana C.4ORCID,Jiang Xuejuan56,Tang Li7ORCID,van den Brandt Piet A.89ORCID,Lu Chih-Ming10,Karagas Margaret R.11ORCID,La Vecchia Carlo12ORCID,Bosetti Cristina13,Polesel Jerry14ORCID,Golka Klaus15ORCID,Zhang Zuo-Feng16ORCID,Villeneuve Paul17,Zeegers Maurice P.2318ORCID,Wesselius Anke2

Affiliation:

1. 1Key Laboratory of Environmental Medicine and Engineering of Ministry of Education, Department of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing, P.R. China.

2. 2School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.

3. 3CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands.

4. 4Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.

5. 5USC Roski Eye Institute, Department of Ophthalmology, University of Southern California, Los Angeles, California.

6. 6Department of Preventive Medicine, University of Southern California, Los Angeles, California.

7. 7Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

8. 8Department of Epidemiology, Maastricht University Medical Centre, GROW- School for Oncology and Developmental Biology, Maastricht, the Netherlands.

9. 9Department of Epidemiology, Maastricht University Medical Centre, Care and Public Health Research Institute (CAPHRI), Maastricht, the Netherlands.

10. 10Department of Urology, Buddhist Dalin Tzu Chi General Hospital, Chiayi County, Taiwan, P.R. China.

11. 11Department of Epidemiology, Geisel School of Medicine at Dartmouth, Hanover, North Hampshire.

12. 12Department of Clinical Medicine and Community Health, University of Milan, Milan, Italy.

13. 13Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

14. 14Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

15. 15Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund, Dortmund, Germany.

16. 16Departments of Epidemiology, UCLA Center for Environmental Genomics, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, California.

17. 17School of Mathematical & Statistics, Carleton University, Ottawa, Canada.

18. 18School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom.

Abstract

Abstract Although evidence suggests that a positive family history of bladder cancer in first-degree relatives is an important risk factor for bladder cancer occurrence, results remain unclear. The influence of family history of nonbladder cancers and more distant relatives on bladder cancer risk is inconsistent. This research, therefore, aims to increase the understanding of the association between family history and bladder cancer risk based on worldwide case–control studies. In total 4,327 cases and 8,948 non-cases were included. Pooled ORs, with corresponding 95% confidence intervals (CI), were obtained using multilevel logistic regression models, adjusted by age, sex, ethnicity, smoking status, and smoking pack-years. The results show bladder cancer risk increased by having a first- or second-degree relative affected with bladder cancer (OR, 2.72; 95% CI, 1.55–4.77 and OR, 1.71; 95% CI, 1.22–2.40, respectively), and nonurologic cancers (OR, 1.61; 95% CI, 1.19–2.18). Moreover, bladder cancer risk increased by number of cancers affected first-degree relatives (for 1 and >1 first-degree relatives: OR, 1.42; 95% CI, 1.02–2.04; OR, 2.67; 95% CI, 1.84–3.86, respectively). Our findings highlight an increased bladder cancer risk for a positive bladder cancer family history in first- and second-degree relatives, and indicate a possible greater effect for an increment of numbers of affected relatives. Prevention Relevance: This study found a positive association between family history and bladder cancer in first- and second-degree relatives, with an added effect attributed to smoking. Given the detriments of bladder cancer, at-risk individuals should receive family history screening and tobacco cessation and avoidance counseling.

Funder

World Cancer Research Fund International

European Commission

Central Universities of China

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3